Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10172 |
| Vaccine Name | COVID-19 aAPC vaccine |
| Disease Name | COVID-19 |
| Disease Classification | Respiratory |
| Virus Name | SARS-CoV-2 virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Replicating viral vector |
| Vaccine Status | Phase 1 |
| Manufacturer | Shenzhen Geno-Immune Medical Institute |
| Year of Manufacturing | 2021 |
| Manufacturing Country | China |
| Age | 6 months - 80 years |
| Dosage | 3 doses on day 0, 14 and 28 |
| Administration Route | Subcutaneous |
| Adjuvant | NA |
| Target Strain | NA |
| Description | The Covid-19/aAPC vaccine is prepared by applying lentivirus modification with immune-modulatory genes and the viral minigenes to the artificial antigen-presenting cells |
| Approving Organisation | NA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | 33816047 |
| Clinical Trial ID | NCT04299724 |
| Reference Link | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003899/ |
| Additional Links | NA |